CPT 2006 Update: Change How You Report Drug Administrations -- or Face Denials

AMA deletes several procedure codes and G codes, replacing them with multiple new codes
If your allergist performs drug infusions, you have a whole new set of codes to learn to report those services correctly. CPT 2006 deleted 90780-90784 and replaced them with new codes for hydration, therapeutic, prophylactic, and diagnostic drug injections and infusions.

This change gives coders more of a selection of CPT codes when a physician administers saline or medication intravenously, says Mary Beth Wass, MS, CMM, manager at The Asthma & Allergy Center in Papillion, Neb.
Use 90760, 90761 for Hydration Services
CPT deleted 90780 (Intravenous infusion for therapy/diagnosis, administered by physician or under direct supervision of physician; up to one hour) and +90781 (… each additional hour, up to eight hours), making way for more specific codes:

• 90760--Intravenous infusion, hydration; initial, up to 1 hour

• +90761--…each additional hour, up to 8 hours.
You’ll use these two new codes for hydration-related services that your allergist provides. You can report 90760 and 90761 for hydration IV infusion of prepackaged fluid and electrolytes, such as saline, but not for the dilution infusion of drugs. As with the old IV infusion codes, 90760 and 90761 require direct physician supervision.
Report 90765-90779 for Drug Administration
In 2005, you had to use codes 90782-90784 or temporary G codes G0345-G0358 to report drug administration services. CPT deletes 90782-90784 for 2006 and offers nine new drug administration codes.

The new drug injection codes are specific to the type of administration (i.e., intravenous, intramuscular, or subcutaneous) and whether the injection is an initial, sequential or concurrent administration. Reporting these codes also requires direct physician supervision.

Tip: If a patient receives a subcutaneous injection of omalizumab (Xolair) under direct supervision of the physician, report 96401 (Chemotherapy administration, subcutaneous or intramuscular; non-hormonal anti-neoplastic), not 90772 (Therapeutic, prophylactic or diagnostic injection [specify substance or drug]; subcutaneous or intramuscular).

Because Xolair is an IgE blocker or inhibitor that is classified as a monoclonal antibody, 96401 is the appropriate code to report to Medicare for Xolair injections. But if there is no direct physician supervision, CPT directs coders to report 99211 (Office or other outpatient visit for the evaluation and management of an established patient, that may not require the presence of a physician) instead of 96401.

You should also report J2357 (Injection, omalizumab, 5 mg) for each 5 mg of Xolair given. Note, however, that certain insurers also require direct physician supervision in order to report 99211 as well, says Carol Pohlig, BSN, RN, CPC, senior coding and education specialist at the University of Pennsylvania department of medicine in Philadelphia.

The new codes 90772-90774 have essentially the same descriptors as the old codes you [...]

- Published on 2006-03-22